| Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study. | |
| | |
MedLine Citation:
|
PMID: 19079957 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Prophylactic use of cabergoline has been associated with a decrease in the severity of ovarian hyperstimulation syndrome (OHSS). A prospective randomized study was designed to evaluate the potential of cabergoline to decrease the incidence of OHSS in high-risk patients undergoing assisted reproductive technology treatment; 166 patients with oestradiol concentrations over 4000 pg/ml on the day of human chorionic gonadotrophin (HCG) administration were evaluated. They all received 20 g routine preventive intravenous human albumin on the day of oocyte retrieval. They were then randomized into two groups: group A (n = 83) received 0.5 mg oral cabergoline per day for 3 weeks beginning on the day after oocyte retrieval, and group B (n = 83) received no medication. 'Early' OHSS was defined as being when the onset of the syndrome was initiated during the first 9 days after HCG administration, and 'late' OHSS was defined as being when the onset of the syndrome was initiated from 10 days after HCG administration. In group A, no patients progressed to 'early' OHSS and nine patients (10.8%) developed 'late' OHSS; in group B, 12 patients (15.0%) progressed to 'early' OHSS and three (3.8%) to 'late' OHSS. Although the risk of 'early' OHSS decreased significantly (P < 0.001), the risk of 'late' onset OHSS did not. The two groups presented no changes in pregnancy, implantation or miscarriages rates. |
| | |
Authors:
|
Carlos Carizza; Vicente Abdelmassih; Soraya Abdelmassih; Pedro Ravizzini; Lister Salgueiro; Paulo Tudech Salgueiro; Lin Tao Jine; Peter Nagy; Roger Abdelmassih |
Related Documents
:
|
9360237 - Effects of oophorectomy and hormone replacement therapy on ophthalmic artery blood flow... 20952527 - The effect of different postweaning altrenogest treatments of primiparous sows on folli... 9228497 - Long-term follow-up on the treatment of endometriosis with the gnrh-agonist buserelinac... 21049017 - Immunocontraception in wild horses (equus caballus) extends reproductive cycling beyond... 14738667 - Management of acute bleeding after laparoscopic roux-en-y gastric bypass. 2923527 - Posterior tibial tendon transfer in spastic equinovarus. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Reproductive biomedicine online Volume: 17 ISSN: 1472-6491 ISO Abbreviation: Reprod. Biomed. Online Publication Date: 2008 Dec |
Date Detail:
|
Created Date: 2008-12-16 Completed Date: 2009-04-24 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101122473 Medline TA: Reprod Biomed Online Country: England |
Other Details:
|
Languages: eng Pagination: 751-5 Citation Subset: IM |
Affiliation:
|
Roger Abdelmassih Human Reproduction Clinic and Research Centre, Avenida Brasil, 1085, São Paulo, SP, Brazil. dr@carloscarizza.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Albumins / metabolism Chorionic Gonadotropin / metabolism Dopamine Agonists / therapeutic use* Ergolines / therapeutic use* Estradiol / metabolism Female Fertilization in Vitro / methods Humans Oocytes / metabolism Ovarian Hyperstimulation Syndrome / drug therapy* Prospective Studies Risk Sperm Injections, Intracytoplasmic / methods Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Albumins; 0/Chorionic Gonadotropin; 0/Dopamine Agonists; 0/Ergolines; 50-28-2/Estradiol; 81409-90-7/cabergoline |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Randomized controlled pilot trial of luteal phase recombinant FSH stimulation in poor responders.
Next Document: A cost per live birth comparison of HMG and rFSH randomized trials.